Browse Source

Add information for publishing with DataCite

Dennis Kaetzel 1 month ago
parent
commit
adbb5cfef2
1 changed files with 65 additions and 0 deletions
  1. 65 0
      datacite.yml

+ 65 - 0
datacite.yml

@@ -0,0 +1,65 @@
+# Metadata for DOI registration according to DataCite Metadata Schema 4.1.
+# For detailed schema description see https://doi.org/10.5438/0014
+
+## Required fields
+
+# The main researchers involved. Include digital identifier (e.g., ORCID)
+# if possible, including the prefix to indicate its type.
+authors:
+  -
+    firstname: "Sampath K.T"
+    lastname: "Kapanaiah"
+    affiliation: "Institute for Applied Physiology, Ulm University, Germany"    
+  -
+    firstname: "Holger"
+    lastname: "Rosenbrock"
+    affiliation: "Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Germany, Biberach an der Riss, Germany"    
+  -
+    firstname: "Bastian"
+    lastname: "Hengerer"
+    affiliation: "Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Germany, Biberach an der Riss, Germany"
+  -
+    firstname: "Dennis"
+    lastname: "Kaetzel"
+    affiliation: "Institute for Applied Physiology, Ulm University, Germany"
+
+# A title to describe the published resource.
+title: "Neural effects of dopaminergic compounds revealed by multi-site electrophysiology in mice and interpretable machine-learning"
+
+# Additional information about the resource, e.g., a brief abstract.
+description: |
+  The LFP_RawData folder contains local field potential (LFP) recordings obtained from depth electrodes in the mice brain regions,
+  including the prelimbic cortex (PrL), mediodorsal thalamus (MD), dorsal hippocampal fissure (dCA1),
+  dorsal hippocampal CA3 subfield (dCA3), and ventral hippocampal fissure (vHC).
+  Pharmaco-LFP experiments were conducted approximately every third day in a within-subject design with a latin-square,
+  randomized drug-assignment across the cohort. Applications included: saline (Sal; vehicle 1),
+  0.1% TWEEN80/saline (T/Sal; vehicle 2), 1 and 3 mg/kg clozapine (CLZ1 and CLZ3; clozapine dihydrochloride, HB6129, HelloBio, GB),
+  0.5 mg/kg raclopride (Raclo; S(-)raclopride(+)-tartrate, R121 Sigma, DE), 0.1 mg/kg SCH23390 (SCH; SCH23390 hydrochloride, 0925 Tocris, GB),
+  and 2 mg/kg amphetamine (Amph; d-amphetamine sulfate, A-5880, Sigma); vehicle 2 was used for raclopride,
+  all other compounds were applied in saline.
+  Mice were recorded in Type-III open-field cages (Tecniplast, IT) with fresh saw-dust for a 10 min baseline period,
+  after which the compound was applied i.p., followed by a further recording for 50 min.
+
+# Lit of keywords the resource should be associated with.
+# Give as many keywords as possible, to make the resource findable.
+keywords:
+  - Neuroscience
+  - Antipsychotics
+  - Neural connectivity
+  - Granger causality
+  - Power spectral density
+  - Electrophysiology
+  - Pharmaco-EEG
+  - Local field potential
+
+# License information for this resource. Please provide the license name and/or a link to the license.
+# Please add also a corresponding LICENSE file to the repository.
+license:
+  name: CC0
+  url: 'http://creativecommons.org/publicdomain/zero/1.0'
+
+# Resource type. Default is Dataset, other possible values are Software, DataPaper, Image, Text.
+resourcetype: Dataset
+
+# Do not edit or remove the following line
+templateversion: 1.2